EntryPoint Capital’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
EntryPoint Capital's BIOA Position: Q3 2026 in Review
EntryPoint Capital opened a new position in BioAge Labs (BIOA) in Q3 2026: 10,261 shares worth $72.8K. The stake represents 0.02% of the portfolio and ranks #708 among its holdings.
162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.
- EntryPoint Capital held 10,261 shares of BioAge Labs worth $72.8K as of Q3 2026.
- BioAge Labs was a new EntryPoint Capital position in Q3 2026.
- BioAge Labs made up 0.02% of EntryPoint Capital's portfolio in Q3 2026, its #708 holding.
- 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.
Based on EntryPoint Capital's 13F filing for Q3 2026, filed 13 Nov 2026.